Phylogenetic analysis of a clinical isolate associated with subclinical Burkholderia pseudomallei infection revealed probable exposure in the British Virgin Islands, where reported infections are limited. Clinicians should consider this geographic distribution when evaluating possible infection among persons with compatible travel history.
Keywords: British Virgin Islands; Burkholderia; Burkholderia pseudomallei; bacteria; melioidosis; molecular epidemiology; travel medicine.